Protecting and survival promoting agent for central nervous cell
AssigneesRiken, Taisho Pharmaceutical Co., Ltd.
InventorsJyunya Mitoma, Shigeki Furuya, Yoshio Hirabayashi
Life of this patent
Estimating the term…
Abstract
An agent for enhancing cell survival of central nerve cells, which comprises a substance selected from the group consisting of L-serine, glycine, and fatty acid compounds thereof as an active ingredient, and a medicament for preventive and/or therapeutic treatment of cerebral dysfunction which comprises said substance as an active ingredient. The substance has an action for protecting cerebral cells to suppress cell death and prolong cell life. For example, cerebral cell death caused by cerebral edema or the raise of intracerebral temperature due to cerebral hemorrhage, cerebral infarction head injury and the like can be suppressed.
Claims20
A method for preventive and/or therapeutic treatment of cerebral dysfunction, comprising:
- administering to a patient in need of such treatment a preventively and/or therapeutically effective amount of a composition comprising at least one of L-serine, glycine, fatty acid compounds thereof, physiologically acceptable salts thereof, hydrates thereof, and solvates thereof.
A method for enhancing central nerve cell survival, comprising:
- intravenously administering by drip infusion in an amount effective for enhancing central nerve cell survival, of a composition to a patient in need of such treatment, wherein the composition comprises at least one of L-serine, glycine, fatty acid compounds thereof, physiologically acceptable salts thereof, hydrates thereof, and solvates thereof.
A method for enhancing central nerve cell survival, comprising:
- ingesting an effective amount of a health drink comprising at least one of L-serine, glycine, fatty acid compounds thereof, physiologically acceptable salts thereof, hydrates thereof, and solvates thereof.
Dependencies are inferred from the claim text.